This report studies the global Biologic Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biologic Therapeutics market by companies, region, type and end-use industry.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2212285
Increasing prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and a growing geriatric population are some other factors contributing to the biologic therapeutics market. In addition, mounting clinical trials and innovative research and development practices to develop novel drugs is boosting the growth of biologic therapeutics market.
On the flip side, manufacturing difficulties due to complexities of drug molecules is challenging the growth of biologic therapeutics market. Nevertheless, increasing research and development in the pharmaceutical sector and rising applications of biologics is anticipated to provide new opportunities to this market.
In 2017, the global Biologic Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global top players, covered
- Pfizer
- Novartis Global
- AstraZeneca
- Merck
- GlaxoSmithKline
- Aurobindo Pharma
Market segment by Regions/Countries, this report covers
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
Browse the complete report @ http://orbisresearch.com/reports/index/global-biologic-therapeutics-market-size-status-and-forecast-2025
Market segment by Type, the product can be split into
- Vaccines
- Blood Products
- Allergenic Extracts
- Human Cells and Tissues
- Gene Therapies
- Protein
- Cellular Therapies
- Xenotransplantation Products
Market segment by Application, split into
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
The study objectives of this report are:
- To study and forecast the market size of Biologic Therapeutics in global market.
- To analyze the global key players, SWOT analysis, value and global market share for top players.
- To define, describe and forecast the market by type, end use and region.
- To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
- To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Biologic Therapeutics are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
- Key Stakeholders
- Biologic Therapeutics Manufacturers
- Biologic Therapeutics Distributors/Traders/Wholesalers
- Biologic Therapeutics Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
- Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the Biologic Therapeutics market, by end-use.
- Detailed analysis and profiles of additional market players.
Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2212285
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
